In the Q1 2026 earnings season, investors are focusing on companies with reliable dividend growth. AbbVie declared a quarterly dividend of $1.73 per share, yielding about 3.3%, continuing its 53-year streak of dividend increases despite a slight EPS guidance cut. Verizon announced a quarterly dividend of $0.7075 per share, yielding around 6.2%, marking over 20 years of consecutive dividend growth. Both companies reported earnings beating estimates and maintain solid fundamentals, making them attractive for income-focused investors amid market uncertainty.
SkinMedica, part of Allergan Aesthetics under AbbVie, has launched a Regenerative Science Advisory Board composed of leading skin health experts to guide future innovation. The company also expanded its R&D facility in Irvine, California, integrating...
Big pharmaceutical companies are confronting a $300 billion loss in drug patents by 2030, prompting a surge in acquisitions of mid-size biotech firms with promising drug pipelines. In 2026, biopharma deal values are expected to exceed $250 billion, t...
